Macromolecular prodrugs. VIII. Synthesis of polymer-gemfibrozil conjugates

International Journal of Pharmaceutics

Volumn 200, Issue 1, 2000, Pages 59-66

  Lovrek, M ^a   Zorc, B ^a   Boneschans, B ^b   Butula, I ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Gemfibrozil; Macromolecular prodrug; Poly DL (2,5 dioxo 1,3 pyrrolidinediyl); Poly , (N 2 hydroxyethyl DL aspartamide) ; Poly , (N 3 hydroxypropyl DL aspartamide) ; Polymer drug conjugate

Indexed keywords

GEMFIBROZIL; POLYMER;

ARTICLE; COVALENT BOND; DRUG CONJUGATION; PRIORITY JOURNAL; SOLUBILITY; SYNTHESIS;

ANTILIPEMIC AGENTS; GEMFIBROZIL; PEPTIDES; POLYHYDROXYETHYL METHACRYLATE; POLYMERS; PRODRUGS; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 0034712820     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00340-9     Document Type: Article

References (23)

1. Aberg F., Appelkvist E.L., Broijersen A., Eriksson M., Angelin B., Hjemdahl P., Dallner G. Gemfibrozil-induced decrease in serum ubiquinone and α-and γ-tocopherol levels in men with combined hyperlipidaemia. Eur. J. Clinic. Invest. 28:1998;235-242.
2. Antoni G., Neri P., Pedersen T.G., Ottesen M. Hydrodynamic properties of a new plasma expander: polyhydroxyethylaspartamide. Biopolymers. 13:1974;1721-1729.
3. Giammona G., Cavallaro G., Pitarresi G., Ventura C., Palazzo S. Synthesis and therapeutic potential of macromolecular prodrug of diflunisal. Int. J. Pharm. 105:1994;57-63.
4. Giammona G., Puglisi G., Cavallaro G., Spadaro A., Pitarresi G. Chemical stability and bioavailability of acyclovir coupled to α,β-poly(N-hydroxyethyl)-DL-aspartamide. J. Controlled Release. 33:1995;261-271.
5. Giammona G., Cavallaro G., Fontana G., Pitarresi G., Carlisi B. Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies. J. Controlled Release. 54:1998;321-331.
6. Hoefle, M.L., 1981. 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentyl ester of 3-pyridine carboxylic acid and use as an antiatherosclerotic agent. US Patent US 4 285 951, 25 Aug.
7. Jakopović M., Zorc B., Biruš M., Butula I. Aspartamide polyhydroxamic acids-synthesis and iron(III) complexes. Croat. Chem. Acta. 69:1996;267-279.
8. Kalčić I., Zorc B., Butula I. Macromolecular prodrugs. VII. Polymer-dopamine conjugates. Int. J. Pharm. 136:1996;31-36.
9. Laruelle, C., Lepant, M., 1991. Preparation of (trimethylcyclohexyl) 2-phenoxyalkyl)-2-propionates as anticholesteremics. PTC Int. Appl. WO 91 07, 373, 30 May.
10. Lovrek, M., Jadrijević-Mladar Takač, M., Zorc, B., Boneschans, B., 2000. Gemfibrozil ester and amide prodrugs - synthesis, spectroscopic characterisation and QSPR (accepted for publication in Die Pharmazie).
11. Miller D.B., Spence J.D. Clinical pharmacokinetics of fibric acid derivatives (fibrates). Clinic. Pharmacokin. 34:1998;155-162.
12. Neri P., Antoni G., Benvenuti F., Cocola F., Gazzei G. Synthesis of α,β-poly[(2-hydroxyethyl)-DL-aspartamide], a new plasma expander. J. Med. Chem. 16:1973;893-897.
13. Piccoli, G., Tarquini, A., Frare, G., 1994. Process for the preparation of gemfibrozil. PTC Int. Appl. WO 94 27 948, 08 Dec.
14. Sircar, I., Holmes, A., 1983. Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents. US Patent US 4 413 011, 01 Nov.
15. Vasey P.A., Kaye S.B., Morrison R., Twelves C., Wilson P., Duncan R. et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates, Cancer Research Campaign Phase I/II Committee. Clin. Cancer Res. 5:1999;83-94.
16. Vlasak J., Rypáček F., Drobník J., Saudek V. Properties and reactivity of polysuccinamide. J. Polym. Sci. Polym. Symp. 66:1979;59-64.
17. Wang, H.P., Lee, O., Fan, C.T., 1996. Preparation of gemfibrozil analogs as anticholesteremic compounds. US Patent US 5 530 145; 25 June.
18. Weintraub M.S., Charach G., Grosskopf I. Effects of fibric acid derivatives and metformin on postprandial lipemia. Atheroschlerosis. 141(Suppl. 1):1998;S71-S75.
19. Zhong P., Yin C. O-Alkylation of 2,5-dimethylphenol. Beijing Shifan Daxue Xuebao, Ziran Kexueban. 28:1992;379-382.
20. Zorc B., Antolić S., Butula I. Macromolecular prodrugs. I. Synthesis of some non-steroidal anti-inflammatory drug esters. Acta Pharm. 43:1993;127-133.
21. Zorc B., Ljubić M., Antolić S, Filipović-Grčić J., Maysinger D., Alebić-Kolbah T., Jalšenjak I. Macromolecular prodrugs. II. Esters of L-dopa and α-methyldopa. Int. J. Pharm. 99:1993;135-143.
22. Zorc B., Butula I. Macromolecular prodrugs. III. Esters of fenoprofen and probenecid. Acta Pharm. 44:1994;103-108.
23. Zorc B., Maysinger D., Kalčić I., Butula I. Macromolecular prodrugs. V. Polymer-broxuridine conjugates. Int. J. Pharm. 123:1995;65-70.